We are live on
!
Find out more
DBG
De Burlo Group Portfolio holdings
AUM
$441M
1-Year Est. Return
21.21%
This Fund
S&P 500
This Quarter
Est. Return
+15.7%
1 Year Est. Return
+21.21%
3 Year Est. Return
+98.05%
5 Year Est. Return
+220.33%
10 Year Est. Return
+1,846.98%
AUM
$550M
AUM Growth
+$193M
(+54%)
Cap. Flow
+$66.2M
Cap. Flow
% of AUM
12.03%
Top 10 Holdings %
Top 10 Hldgs %
37.74%
Holding
95
New
27
Increased
22
Reduced
33
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Church & Dwight Co
CHD
|
+$17.8M |
| 2 |
Canadian Pacific Kansas City
CP
|
+$14.7M |
| 3 |
Abbott
ABT
|
+$14.4M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$14.3M |
| 5 |
Clorox
CLX
|
+$12.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$20.4M |
| 2 |
NextEra Energy
NEE
|
+$17.3M |
| 3 |
Adobe
ADBE
|
+$16.2M |
| 4 |
Lumentum
LITE
|
+$11.7M |
| 5 |
FISV
Fiserv Inc
FISV
|
+$11M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.99% |
| 2 | Healthcare | 19.78% |
| 3 | Financials | 11.08% |
| 4 | Industrials | 10.58% |
| 5 | Consumer Discretionary | 7.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Royal Gold
RGLD
$17.1B
| $312K | 0.06% |
2,600
| – | – |
|
77
Johnson & Johnson
JNJ
$635B
| $298K | 0.05% |
2,000
+200
| +11% | +$29.6K |
|
78
Linde
LIN
$237B
| $286K | 0.05% |
1,200
| – | – |
|
79
Cognizant
CTSH
$21.5B
| $230K | 0.04% |
+3,308
| New | +$215K |
|
80
Eli Lilly
LLY
$1.07T
| $224K | 0.04% |
+1,514
| New | +$234K |
|
|
81
Vertex Pharmaceuticals
VRTX
$121B
| $220K | 0.04% |
810
-74,110
| -99% | -$20.4M |
|
82
Arista Networks
ANET
$219B
| $207K | 0.04% |
16,000
-1,600
| -9% | -$22K |
|
|
FISV
83
Fiserv Inc
FISV
$27.2B
| $206K | 0.04% |
2,000
-110,100
| -98% | -$11M |
|
84
Netflix
NFLX
$292B
| $200K | 0.04% |
+4,000
| New | +$199K |
|
85
Oracle
ORCL
$331B
| $185K | 0.03% |
+3,100
| New | +$176K |
|
86
Zoetis
ZTS
$31.6B
| $140K | 0.03% |
+850
| New | +$131K |
|
87
Allstate
ALL
$66.9B
| – | – |
-81,000
| Closed | -$7.43M |
|
88
Bright Horizons
BFAM
$3.99B
| – | – |
-8,300
| Closed | -$847K |
|
89
Comcast
CMCSA
$79.1B
| – | – |
-238,300
| Closed | -$8.19M |
|
90
Centene
CNC
$31.3B
| – | – |
-123,500
| Closed | -$7.34M |
|
|
91
Lumentum
LITE
$59.4B
| – | – |
-158,300
| Closed | -$11.7M |
|
92
Medtronic
MDT
$107B
| – | – |
-91,300
| Closed | -$8.23M |
|
93
Stryker
SYK
$127B
| – | – |
-12,900
| Closed | -$2.15M |
|
94
Tradeweb Markets
TW
$21.3B
| – | – |
-157,000
| Closed | -$6.6M |
|
|
VAR
95
DELISTED
Varian Medical Systems, Inc.
VAR
| – | – |
-29,515
| Closed | -$3.03M |
|
Similar funds
ECA
DWML
BOA
PLU
CPW
CAAM
SCP
EFMC
De Burlo Group's Q3 2020 Portfolio in Review
As of Q3 2020, De Burlo Group held 95 positions worth $550M, up 54% from $357M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
De Burlo Group deployed $66.2M of net new capital in Q3 2020, opening 27 new positions and adding to 22 existing holdings. Its largest new stake was Canadian Pacific Kansas City: 257,500 shares worth $15.7M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 34% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $20.4M trimmed.
- De Burlo Group's largest Q3 2020 buy was Canadian Pacific Kansas City: 257,500 shares worth $15.7M.
- De Burlo Group added most to Church & Dwight Co in Q3 2020, an estimated $17.8M increase.
- De Burlo Group's biggest Q3 2020 reduction was Vertex Pharmaceuticals, cutting an estimated $20.4M.
- De Burlo Group fully exited Lumentum in Q3 2020, selling an estimated $11.7M.
- De Burlo Group's ten largest holdings make up 38% of its $550M portfolio in Q3 2020.
- De Burlo Group opened 27 new positions and closed 9 in Q3 2020.
- De Burlo Group's portfolio value rose 54% quarter-over-quarter to $550M.
Based on De Burlo Group's 13F filing for Q3 2020, filed 5 Nov 2020.